These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6317510)

  • 1. [Antibiotic prevention in gynecology. Concentrations of ceftizoxime in the serum, myometrium, endometrium and fallopian tubes].
    Daschner F; Just HM; Brändle J; Zahn V
    Geburtshilfe Frauenheilkd; 1983 Nov; 43(11):683-5. PubMed ID: 6317510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic prophylaxis in gynecology: cefoxitin concentrations in serum, myometrium, endometrium and salpinges.
    Daschner F; Petersen E; Langmaack H; Trennhäuser M
    Infection; 1982; 10(6):341-2. PubMed ID: 7152685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibiotic prevention in hysterectomy. Effectivity of a single preoperative ceftriaxon dose].
    Petersen EE; Daschner FD; Pelz K; Birmelin G; Hillemanns HG
    Geburtshilfe Frauenheilkd; 1983 Aug; 43(8):492-7. PubMed ID: 6311659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penetration of ceftazidime into serum, myometrium, endometrium, salpinges and subcutaneous tissue.
    Daschner FD; Petersen EE; Just HM; Hillemanns HG
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():247-9. PubMed ID: 6352627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration of cefotetan into serum, myometrium, endometrium and salpinges.
    Just HM; Petersen EE; Bassler M; Frank U; Daschner FD
    Chemotherapy; 1984; 30(5):305-7. PubMed ID: 6593163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penetration of cefmenoxime into serum, gynecologic tissues, and heart valves.
    Daschner FD; Petersen EE; Frank U; Hornig D
    Am J Med; 1984 Dec; 77(6A):4-6. PubMed ID: 6097123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of a double-blind, placebo-controlled clinical trial program of single-dose ceftizoxime versus multiple-dose cefoxitin as prophylaxis for patients undergoing vaginal and abdominal hysterectomy.
    McGregor JA; Phillips LE; Roy S; Dunne JT; Warwaruk AS; Johnston DW; Yuzpe AA; Hemsell DL
    J Am Coll Surg; 1994 Feb; 178(2):123-31. PubMed ID: 8173721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftriaxone and cefazolin prophylaxis for hysterectomy.
    Hemsell DL; Johnson ER; Bawdon RE; Hemsell PG; Nobles BJ; Heard ML
    Surg Gynecol Obstet; 1985 Sep; 161(3):197-203. PubMed ID: 3898440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentrations of ceftriaxone in serum and gynecological tissues.
    Daschner FD; Petersen EE; Brändle J; Hillemanns HG
    Chemotherapy; 1983; 29(2):153-5. PubMed ID: 6301774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tissue concentration of ceftizoxime in the lung].
    Adam D; König J
    Arzneimittelforschung; 1983; 33(3):427-9. PubMed ID: 6307319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diffusion of aztreonam in the tissues and biological fluids of the female genital tract].
    Berthelot G; Bergogne-Bérézin E; Vernant D; Ravina JH
    Pathol Biol (Paris); 1986 May; 34(5):339-41. PubMed ID: 3534702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma and tissue concentrations of ceforanide and cefazolin in women undergoing hysterectomy.
    Souney PF; Fisher S; Tuomala RE; Polk BF; Simpson C
    Chemotherapy; 1988; 34(3):185-90. PubMed ID: 3416659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum and tissue concentrations of cefoxitin and cefamandole in women undergoing hysterectomy.
    French MA; Quintiliani R; Nightingale CH; Russo JN
    Obstet Gynecol; 1983 Jan; 61(1):42-7. PubMed ID: 6823348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftriaxone or cefazolin prophylaxis for the prevention of infection after vaginal hysterectomy.
    Hemsell DL; Menon MO; Friedman AJ
    Am J Surg; 1984 Oct; 148(4A):22-6. PubMed ID: 6091476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of single-dose ceftizoxime vs. multiple-dose cefoxitin in preventing infection after vaginal hysterectomy.
    Roy S; Wilkins J; Hemsell DL; March CM; Spirtos NM
    J Reprod Med; 1988 Jan; 33(1 Suppl):149-53. PubMed ID: 3422693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of single-dose ceftizoxime with multidose cefoxitin chemoprophylaxis for patients undergoing hysterectomy.
    McGregor JA; French JI; McKinney PJ; Milligan K
    Clin Ther; 1990; 12 Suppl C():45-52. PubMed ID: 2202511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial and vaginal cuff bacteria recovered at elective hysterectomy during a trial of antibiotic prophylaxis.
    Grossman JH; Adams RL; Hierholzer WJ; Andriole VT
    Am J Obstet Gynecol; 1978 Feb; 130(3):312-6. PubMed ID: 623171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prostatic tissue levels of ceftizoxime].
    Hoshi S; Kimura M; Kuwahara M; Orikasa S; Nakano S; Chiba R; Ishii N; Kato M; Morita M; Kato H
    Hinyokika Kiyo; 1985 May; 31(5):863-70. PubMed ID: 3901702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic antibiotics in patients undergoing total vaginal or abdominal hysterectomy.
    Tchabo JG; Cutting ME; Butler C
    Int Surg; 1985; 70(4):349-52. PubMed ID: 3914473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic implications of doxycycline and cephalothin concentrations in the female genital tract.
    Whelton A; Blanco LJ; Carter GG; Craig TJ; Bryant HH; Herbst DV; King TM
    Obstet Gynecol; 1980 Jan; 55(1):28-32. PubMed ID: 7352059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.